Scarica l'app Stockscreener
19.50
2.58%
0.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$19.01
Aprire:
$19.1
Volume 24 ore:
1.83M
Relative Volume:
0.79
Capitalizzazione di mercato:
$1.34B
Reddito:
$1.03B
Utile/perdita netta:
$-94.55M
Rapporto P/E:
-13.92
EPS:
-1.4012
Flusso di cassa netto:
$-3.64M
1 W Prestazione:
+13.90%
1M Prestazione:
+29.22%
6M Prestazione:
-1.96%
1 anno Prestazione:
+25.16%
Intervallo 1D:
$18.56
$19.66
Intervallo di 1 settimana:
$16.34
$19.66
Portata 52W:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Nome
Tandem Diabetes Care Inc
Settore
Industria
Telefono
858-366-6900
Indirizzo
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
19.50 | 1.18B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-19 | Aggiornamento | Truist | Hold → Buy |
| 2026-03-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | Aggiornamento | Lake Street | Hold → Buy |
| 2026-02-20 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2026-01-27 | Ripresa | TD Cowen | Buy |
| 2025-12-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | Ripresa | Stifel | Hold |
| 2025-09-08 | Iniziato | Oppenheimer | Outperform |
| 2025-08-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Downgrade | Citigroup | Neutral → Sell |
| 2025-06-16 | Iniziato | Truist | Hold |
| 2025-04-10 | Iniziato | Mizuho | Neutral |
| 2025-03-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-03-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-10-04 | Iniziato | Goldman | Neutral |
| 2024-10-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-04-29 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Aggiornamento | Stifel | Hold → Buy |
| 2023-08-04 | Downgrade | Citigroup | Buy → Neutral |
| 2023-05-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-08-09 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Iniziato | Wells Fargo | Overweight |
| 2020-07-31 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-18 | Reiterato | Raymond James | Outperform |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-06 | Iniziato | Raymond James | Outperform |
| 2020-02-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Iniziato | Guggenheim | Buy |
| 2019-10-04 | Aggiornamento | UBS | Neutral → Buy |
| 2019-05-17 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-13 | Iniziato | SVB Leerink | Outperform |
| 2019-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2019-03-05 | Reiterato | BofA/Merrill | Neutral |
| 2019-02-27 | Reiterato | Lake Street | Buy |
| 2018-11-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Reiterato | Dougherty & Company | Buy |
| 2018-09-26 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
TNDM|Tandem Diabetes Care Inc|Price:17.170|Chg%:+0.050 - TradingKey
Tandem Diabetes Care Inc (TNDM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tandem Diabetes Care Inc (TNDM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tandem Diabetes Care (TNDM) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Tandem Diabetes Care (TNDM) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
TradingKey - TradingKey
Impact of Automated Insulin Delivery on Type 2 Diabetes Measures - AJMC
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Insulin Pump Maker Moves To Dismiss Wrongful Death Case On Preemption Grounds - Mealey's
3 Healthcare Stocks with Questionable Fundamentals - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
What Tandem Diabetes Care (TNDM)'s CGM Expansion and New Tubeless Rival Mean For Shareholders - Sahm
Understanding the Setup: (TNDM) and Scalable Risk - Stock Traders Daily
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 60% Potential Upside with Robust Buy Ratings - DirectorsTalk Interviews
Tandem Diabetes Care Inc (TNDM) Shares Surge 6.0% -- What GF Sco - GuruFocus
TNDM6032036 Bond Coupon Profile — Rate & Payments - TradingView
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
Tandem Diabetes Care (0M0F) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Can Tandem Diabetes Care (TNDM) Turn Revenue Beats Into Durable Returns On Capital? - webull.com
When Will Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Become Profitable? - 富途牛牛
Tandem Diabetes Care Inc (TNDM) Shares Surge 4.9% -- What GF Sco - GuruFocus
Form 4 Tandem Diabetes Care Inc For: 17 July By Investing.com - Investing.com Nigeria
Tandem Diabetes Care (TNDM) COO logs RSU vesting, 31,741 shares held after tax withholding - Stock Titan
US875372AE4 Bond Profile — Key Metrics - TradingView
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks - Yahoo Finance
Mizuho Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Cuts Target Price to $20 - Moomoo
TNDM Maintained by Mizuho -- Price Target Lowered to $20.00 - GuruFocus
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX) - The Globe and Mail
Tandem Diabetes Care (TNDM) Expands Abbott Compatibility As Undervalued Narrative Faces A Fresh Test - Sahm
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM? - Yahoo Finance
No Title Or Subtitle Provided To Check - Finimize
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion? - Yahoo Finance
Tandem’s Expanded Libre 3 Plus Integration Could Be A Game Changer For Tandem Diabetes Care (TNDM) - Sahm
Tandem Diabetes Care (TNDM) Goldman Sachs 46th Annual Global Healthcare Conference summary - Quartr
Tandem Diabetes Care Inc. (TNDM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $17 - Moomoo
Tandem Diabetes Care (TNDM) Stifel 2024 Healthcare Conference Summary - Quartr
Does TNDM Stock Still Deserve a Place in Your Portfolio? - TradingView
Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)’s Transition Risks? - Insider Monkey
10 Best Get Rich Quick Stocks to Buy Right Now - Insider Monkey
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility With Abbott's FreeStyle Libre 3 Plus CGM Sensor - Medical Product Outsourcing
Tandem Diabetes Q1 2026 slides: record revenue, profitability returns - Investing.com
TNDMTandem Diabetes Care Inc Options - Finviz
Tandem Diabetes faces earnings test as pay-as-you-go shift weighs - Investing.com
ETFs Investing in Tandem Diabetes Care, Inc. Stocks - TradingView
TANDEM DIABETES CARE INC (TNDM) Stock Chart - ChartMill
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care (TNDM) Expands Compatibility with Abbott's FreeStyle Libre 3 Plus - GuruFocus
Tandem Diabetes Care Inc Azioni (TNDM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):